|

Conventional Anemia Management Clinical Trials

2 actively recruiting trials

Also known as: Erythropoiesis-Stimulating Agent, Iron Supplementation

Pipeline

Phase 1/2: 2

Top Sponsors

  • Mansoura University2

Indications

  • Anemia in End Stage Renal Disease2
  • Kidney Failure, Chronic2
  • Malnutrition-Inflammation Syndrome1
  • Cardiovascular Diseases (CVD)1
  • Heart Disease1

Other2 trials

Roxadustat for Bone and Neuropsychiatric Aspects in Hemodialysis Patients
Phase 1/2
Roxadustat's Effect on Heart, Nutrition, and Inflammation in Hemodialysis Patients
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.